Real-time · AI · Cross-signal
Discover the power of real-time signals plus AI
Every funding round, exec hire, M&A move, contract, and sentiment shift on CroíValve — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
CroíValve raised $16 million in a Series B financing round led by the MedTech & Irrus Syndicates to fund the TANDEM II Early Feasibility Study of its DUO™ System for treating tricuspid regurgitation.
PRIVATEAug 07, 2024•almost 2 years ago
Amount Raised
$16 Million
Round Type
series b
DublinInvestors
Iag Capital PartnersSosvElkstoneEnterprise IrelandAtlantic Bridge University FundBroadview VenturesFurthrAscentifiMed Tech & Irrus Syndicates
Description
CroíValve announced the closing of $16 million Series B financing, with participation from current investors and new investor IAG Capital Partners. The funds will be used for an FDA-approved, prospective study to evaluate the safety and performance of the DUO™ System in patients with severe tricuspid regurgitation.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Watching CroíValve? See every signal — funding, hires, M&A, contracts, sentiment.
See plans